ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-α1 transgene efficacy

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The purpose of this study was to determine the role of ICAM-1 in ocular herpes simplex virus type 1 (HSV-1) infection. Wild-type and ICAM-1 knockout mice were assessed for resistance to ocular HSV-1 infection in the presence of naked DNA plasmid vector or plasmid DNA encoding interferon-α1 topically applied to the cornea of the mice. Wild-type mice showed greater resistance to HSV-1 infection compared to ICAM-1 knockout mice as measured by cumulative survival. The absence of ICAM-1 did not affect the efficacy of the interferon-α1 transgene against ocular HSV-1. Both ICAM-1 and wild-type mice treated with the transgene showed a reduction in viral load and antigen expression in the trigeminal ganglion compared to the plasmid vector-treated counterparts. In contrast, the presence of the transgene reduced the number of infiltrating cells into the cornea in comparison to plasmid vector DNA controls in the wild-type mice but not in the ICAM-1 knockout mice. Collectively, these results suggest that the IFN-α1 transgene can restore resistance against HSV-1 infection in ICAM-1-deficient mice. © 2001 Academic Press.

Author supplied keywords

Cite

CITATION STYLE

APA

Noisakran, S., Härle, P., & Carr, D. J. J. (2001). ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-α1 transgene efficacy. Virology, 283(1), 69–77. https://doi.org/10.1006/viro.2001.0858

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free